An AllTrials project

NCT03719586: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)

This trial has reported, although it was 112 days late in doing so.

Full data

Full entry on ClinicalTrials.gov NCT03719586
Title A Multicenter, Multi-Outbreak, Randomized, Controlled Safety and Efficacy Study of Investigational Therapeutics for the Treatment of Patients With Ebola Virus Disease
Results Status Reported (late)
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Nov. 21, 2018
Completion date Sept. 9, 2019
Required reporting date Sept. 8, 2020, midnight
Actual reporting date Dec. 30, 2020
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late 112